相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Increased tumor cell expression of Axl is a marker of aggressive features in breast cancer among African women
Lavina Ahmed et al.
APMIS (2015)
Hypoxia-inducible factor 1 and breast cancer metastasis
Zhao-ji Liu et al.
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B (2015)
Expression of HIF-1α and Markers of Angiogenesis Are Not Significantly Different in Triple Negative Breast Cancer Compared to Other Breast Cancer Molecular Subtypes: Implications for Future Therapy
Lamis Yehia et al.
PLOS ONE (2015)
HIF-1α Promotes Epithelial-Mesenchymal Transition and Metastasis through Direct Regulation of ZEB1 in Colorectal Cancer
Wenjing Zhang et al.
PLOS ONE (2015)
Clinicopathologic Features of Breast Carcinomas Classified by Biomarkers and Correlation with Microvessel Density and VEGF Expression: A Study from Thailand
Tuenjai Chuangsuwanich et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
The basal epithelial marker P-cadherin associates with breast cancer cell populations harboring a glycolytic and acid-resistant phenotype
Barbara Sousa et al.
BMC CANCER (2014)
Differences in biological features of breast cancer between Caucasian (Italian) and African (Tanzanian) populations
D. Amadori et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Pilot trial of EZN-2968, an antisense oligonucleotide inhibitor of hypoxia-inducible factor-1 alpha (HIF-1α), in patients with refractory solid tumors
Woondong Jeong et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2014)
Weekly EZN-2208 (PEGylated SN-38) in combination with bevacizumab in patients with refractory solid tumors
Woondong Jeong et al.
INVESTIGATIONAL NEW DRUGS (2014)
Targeting hypoxia-inducible factor-1α (HIF-1α) in combination with antiangiogenic therapy: A phase I trial of bortezomib plus bevacizumab
Gerald S. Falchook et al.
ONCOTARGET (2014)
Expression of aldehyde dehydrogenase after neoadjuvant chemotherapy is associated with expression of hypoxia-inducible factors 1 and 2 alpha and predicts prognosis in locally advanced breast cancer
Daniel Guimaraes Tiezzi et al.
CLINICS (2013)
Breast cancer as a systemic disease: a view of metastasis
A. J. Redig et al.
JOURNAL OF INTERNAL MEDICINE (2013)
First Axl inhibitor enters clinical trials
Cormac Sheridan
NATURE BIOTECHNOLOGY (2013)
Metabolism-Related Proteins Are Differentially Expressed according to the Molecular Subtype of Invasive Breast Cancer Defined by Surrogate Immunohistochemistry
Junjeong Choi et al.
PATHOBIOLOGY (2013)
Molecular Phenotypes in Triple Negative Breast Cancer from African American Patients Suggest Targets for Therapy
Robert Lindner et al.
PLOS ONE (2013)
MiR-21 regulates epithelial-mesenchymal transition phenotype and hypoxia-inducible factor-1a expression in third-sphere forming breast cancer stem cell-like cells
Mingli Han et al.
CANCER SCIENCE (2012)
Hypoxia Stabilizes GAS6/Axl Signaling in Metastatic Prostate Cancer
Anjali Mishra et al.
MOLECULAR CANCER RESEARCH (2012)
Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
A. Goldhirsch et al.
ANNALS OF ONCOLOGY (2011)
Hypoxia-inducible factor 1 alpha represses the transcription of the estrogen receptor alpha gene in human breast cancer cells
Kwanghee Ryu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Vascular proliferation is increased in basal-like breast cancer
Hawa Nalwoga et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
The association between vascular endothelial growth factor expression in invasive breast cancer and survival varies with intrinsic subtypes and use of adjuvant systemic therapy: results from the Nurses' Health Study
Ying Liu et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Differential Impact of EGFR-Targeted Therapies on Hypoxia Responses: Implications for Treatment Sensitivity in Triple-Negative Metastatic Breast Cancer
Abderrahim El Guerrab et al.
PLOS ONE (2011)
Analysis of tumor environmental response and oncogenic pathway activation identifies distinct basal and luminal features in HER2-related breast tumor subtypes
Michael L. Gatza et al.
BREAST CANCER RESEARCH (2011)
Expression of aldehyde dehydrogenase 1 (ALDH1) is associated with basal-like markers and features of aggressive tumours in African breast cancer
H. Nalwoga et al.
BRITISH JOURNAL OF CANCER (2010)
R428, a Selective Small Molecule Inhibitor of Axl Kinase, Blocks Tumor Spread and Prolongs Survival in Models of Metastatic Breast Cancer
Sacha J. Holland et al.
CANCER RESEARCH (2010)
Hypoxia-Inducible Factor 1α Determines Gastric Cancer Chemosensitivity via Modulation of p53 and NF-κB
Nadine Rohwer et al.
PLOS ONE (2010)
Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival
Christine Gjerdrum et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Significantly higher levels of vascular endothelial growth factor (VEGF) and shorter survival times for patients with primary operable triple-negative breast cancer
B. K. Linderholm et al.
ANNALS OF ONCOLOGY (2009)
The key hypoxia regulated gene CAIX is upregulated in basal-like breast tumours and is associated with resistance to chemotherapy
E. Y. Tan et al.
BRITISH JOURNAL OF CANCER (2009)
Axl as a potential therapeutic target in cancer: role of Axl in tumor growth, metastasis and angiogenesis
Y. Li et al.
ONCOGENE (2009)
Differences in the Tumor Microenvironment between African-American and European-American Breast Cancer Patients
Damali N. Martin et al.
PLOS ONE (2009)
Expression of EGFR and c-kit is associated with the basal-like phenotype in breast carcinomas of African women
Hawa Nalwoga et al.
APMIS (2008)
Redox mechanisms switch on hypoxia-dependent epithelial-mesenchymal transition in cancer cells
Stefania Cannito et al.
CARCINOGENESIS (2008)
Hypoxia-inducible factor (HIF)-1α directly enhances the transcriptional activity of stem cell factor (SCF) in response to hypoxia and epidermal growth factor (EGF)
Zhi-Bo Han et al.
CARCINOGENESIS (2008)
Lesson of the Month - Independent prognostic value of the basal-like phenotype of breast cancer and associations with EGFR and candidate stem cell marker BMI-1
J. B. Arnes et al.
HISTOPATHOLOGY (2008)
Direct regulation of TWIST by HIF-1α promotes metastasis
Muh-Hwa Yang et al.
NATURE CELL BIOLOGY (2008)
Hypoxia-inducible factor 1α is closely linked to an aggressive phenotype in breast cancer
Yutaka Yamamoto et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Frequency of the basal-like phenotype in African breast cancer
Hawa Nalwoga et al.
APMIS (2007)
Hypoxia inducible factor-1-independent pathways in tumor angiogenesis
Yusuke Mizukami et al.
CLINICAL CANCER RESEARCH (2007)
Differences in breast carcinoma characteristics in newly diagnosed African-American and Caucasian patients - A single-institution compilation compared with the National Cancer Institute's Surveillance, Epidemiology, and End Results Database
Gloria J. Morris et al.
CANCER (2007)
Hypoxia-inducible factor-1α-expression predicts a poor response to primary chemoendocrine therapy and disease-free survival in primary human breast cancer
Daniele Generali et al.
CLINICAL CANCER RESEARCH (2006)
Imatinib inhibits c-Kit-induced hypoxia-inducible factor-1α activity and vascular endothelial growth factor expression in small cell lung cancer cells
Julie Litz et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Hypoxia inducible factor-1α is a prognostic marker in premenopausal patients with intermediate to highly differentiated breast cancer but not a predictive marker for tamoxifen response
Å Kronblad et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Vascular endothelial growth factor expression in the basal subtype of breast carcinoma
A Ribeiro-Silva et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2006)
Vascular proliferation is important for clinical progress of endometrial cancer
IM Stefansson et al.
CANCER RESEARCH (2006)
Hypoxia-inducible factor-1 alpha is associated with angiogenesis, and expression of bFGF, PDGF-BB, and EGFR in invasive breast cancer
R Bos et al.
HISTOPATHOLOGY (2005)
Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma
TO Nielsen et al.
CLINICAL CANCER RESEARCH (2004)
Hypoxia-inducible factor 1 alpha in high-risk breast cancer: an independent prognostic parameter?
G Gruber et al.
BREAST CANCER RESEARCH (2004)
Expression of hypoxia-inducible factor-1 alpha and cell cycle proteins in invasive breast cancer are estrogen receptor related
R Bos et al.
BREAST CANCER RESEARCH (2004)
Levels of hypoxia-inducible factor-1α independently predict prognosis in patients with lymph node negative breast carcinoma
R Bos et al.
CANCER (2003)
Hypoxia-induced pathways in breast cancer
TI Goonewardene et al.
MICROSCOPY RESEARCH AND TECHNIQUE (2002)
Hypoxia - A key regulatory factor in tumour growth
AL Harris
NATURE REVIEWS CANCER (2002)
HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1α (HIF-1α) synthesis:: Novel mechanism for HIF-1-mediated vascular endothelial growth factor expression
E Laughner et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Levels of hypoxia-inducible factor-1α during breast carcinogenesis
R Bos et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
分享论文
